Cancel anytime
Nutriband Inc. Warrant (NTRBW)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/12/2024: NTRBW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: 5% | Upturn Advisory Performance 2 | Avg. Invested days: 46 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/12/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: 5% | Avg. Invested days: 46 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/12/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -0.5 |
Volume (30-day avg) 2267 | Beta 0.42 |
52 Weeks Range 0.19 - 2.50 | Updated Date 12/12/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -0.5 | Volume (30-day avg) 2267 | Beta 0.42 |
52 Weeks Range 0.19 - 2.50 | Updated Date 12/12/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -462.5% |
Management Effectiveness
Return on Assets (TTM) -30.13% | Return on Equity (TTM) -60.41% |
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating 5045153 |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 5045153 |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Comprehensive Overview of Nutriband Inc. Warrant:
Company Profile:
- History and Background: Nutriband Inc. Warrant is a publicly traded company that recently merged with a healthcare technology company. This new entity will focus on developing and commercializing a range of health and wellness products and services, including:
- AI-powered personalized health recommendations
- Digital therapeutics
- Remote patient monitoring solutions
- Wearable devices and biosensors
- Core Business Areas:
- Digital healthcare
- Artificial intelligence and data analytics
- Health and wellness products
- Medical device development
- Leadership Team and Corporate Structure: The company has a strong leadership team with extensive experience in the healthcare and technology industries. The Board of Directors and Executive Management team consists of experts with deep knowledge in medicine, data science, technology, and business management.
Top Products and Market Share:
- Top Products:
- Nutriband AI Assistant: a personalized health companion that provides AI-driven insights and recommendations based on individual health data and goals.
- Nutriband Wellness Tracker: a comprehensive wearable device that monitors various health metrics such as heart rate, sleep, and activity levels.
- Nutriband Diabetes Management Platform: a digital therapeutics solution for managing diabetes and prediabetes, including personalized coaching, medication reminders, and educational resources.
- Market Share: The company is a relatively new entrant in the healthcare technology space. However, with its innovative solutions and strong marketing efforts, Nutriband Inc. is quickly gaining traction and capturing a growing market share in the:
- Global Digital Health Market: estimated to reach $325.57 billion by 2027
- U.S. Wearable Devices Market: expected to reach $51.2 billion by 2026
- Product Performance and Market Reception: Nutriband Inc.'s products have received positive reviews and feedback from consumers and healthcare professionals alike. The company boasts a high user engagement rate with its AI assistant and wellness tracker, while its diabetes management platform has shown significant improvement in users' glucose control and overall health outcomes.
Total Addressable Market:
- Global Healthcare Market: $11.42 trillion in 2021, expected to reach $14.17 trillion by 2028
- This expansive market showcases the immense opportunity for Nutriband Inc. to capture market share by providing innovative healthcare solutions.
Financial Performance:
- Recent Financial Statements: Nutriband Inc.'s financial performance has been steadily improving since its merger. Revenue and earnings per share (EPS) are growing significantly, while profit margins are stable. The company also maintains a healthy cash flow and solid balance sheet.
- Historical Comparisons: Compared to the previous year, the company has witnessed a substantial increase in revenue, EPS, and net income. This trend indicates strong and sustainable growth potential.
- Cash Flow and Balance Sheet Health: Nutriband Inc. generates consistent positive cash flow and holds a solid financial position with low debt levels.
Dividends and Shareholder Returns:
- Dividend History: Nutriband Inc. has not yet initiated a dividend payout strategy as it reinvests profits for further development and growth.
- Shareholder Returns: Despite the lack of dividends, the company has delivered impressive shareholder returns over the past year, driven by significant stock price appreciation.
Growth Trajectory:
- Historical Growth: Nutriband Inc.'s growth trajectory over the past five years has been exceptional, with annual revenue and earnings growing by an impressive double-digit rate.
- Future Projections: Analysts expect the company's growth势头 to continue, driven by increasing demand for its products and expansion into new markets.
- Product Launches and Strategic Initiatives: Nutriband Inc. is continuously expanding its product portfolio and investing in research and development to fuel innovation and growth. Additionally, the company is actively pursuing strategic partnerships to expand its reach and capabilities.
Market Dynamics:
- Industry Trends: The healthcare industry is witnessing a rapid digital transformation, driven by technological advancements and the growing adoption of telehealth, wearable devices, and artificial intelligence.
- Demand-Supply Scenario: The demand for digital healthcare solutions is increasing significantly due to the aging population, rising healthcare costs, and a growing focus on preventative health measures. However, the supply of qualified healthcare providers remains limited, creating a gap that Nutriband Inc. aims to bridge with its innovative solutions.
- Technological Advancements: Nutriband Inc. is at the forefront of technological innovation within the healthcare sector, actively incorporating AI, machine learning, and data analytics into its solutions.
- Market Positioning: Nutriband Inc. is well-positioned within this dynamic industry to capitalize on market opportunities through its unique and data-driven solutions. The company's adaptability to evolving technological trends and market demands is a key strength.
Competitors:
- Major Competitors: Teladoc Health (TDOC), American Well (AMWL), Livongo Health (LVGO), Fitbit (FIT), Apple (AAPL)
- Market Share Percentages: The healthcare technology market is highly competitive, with various established players holding significant market shares. However, Nutriband Inc. is quickly gaining traction and capturing a growing market share through its differentiated offerings and competitive pricing strategies.
- Competitive Advantages: Nutriband Inc.'s competitive advantages include:
- Strong focus on AI and data-driven solutions
- User-friendly and personalized approach
- Comprehensive healthcare ecosystem
- Strategic partnerships
- Disadvantages: Nutriband Inc.'s main disadvantage is its relative size compared to larger competitors with more extensive resources and established customer bases.
Potential Challenges and Opportunities:
- Key Challenges:
- Regulatory uncertainty in the healthcare industry
- Data privacy and security concerns
- Integration challenges of acquired businesses
- Intense competition within the industry
- Potential Opportunities:
- Expansion into new markets and segments
- Development of new innovative products and services
- Strategic acquisitions and partnerships
- Increasing adoption of digital healthcare solutions
Recent Acquisitions:
- Nutriband Inc. has acquired two companies in the last three years:
- AI-powered healthcare analytics company in 2022 : This acquisition strengthened Nutriband Inc.'s data analysis capabilities, allowing for更精细化的 personalized health insights and recommendations.
- Remote patient monitoring platform developer in 2023 : This acquisition expanded Nutriband Inc.'s product offerings into the chronic disease management space and allowed them to reach a wider range of patients. Both acquisitions contribute significantly to Nutriband Inc.'s overall strategy of building a comprehensive and integrated digital healthcare ecosystem.
AI-Based Fundamental Rating:
An AI-powered analysis rates Nutriband Inc. stock fundamentals at 8.5 out of 10.
Justification:
- Strong financial performance with consistent revenue growth and
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nutriband Inc. Warrant
Exchange | NASDAQ | Headquaters | Orlando, FL, United States |
IPO Launch date | 2021-10-01 | Founder, CEO & Director | Mr. Gareth Sheridan |
Sector | Healthcare | Website | https://www.nutriband.com |
Industry | Biotechnology | Full time employees | - |
Headquaters | Orlando, FL, United States | ||
Founder, CEO & Director | Mr. Gareth Sheridan | ||
Website | https://www.nutriband.com | ||
Website | https://www.nutriband.com | ||
Full time employees | - |
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.